Literature DB >> 21300786

Selective abrogation of BiP/GRP78 blunts activation of NF-κB through the ATF6 branch of the UPR: involvement of C/EBPβ and mTOR-dependent dephosphorylation of Akt.

Shotaro Nakajima1, Nobuhiko Hiramatsu, Kunihiro Hayakawa, Yukinori Saito, Hironori Kato, Tao Huang, Jian Yao, Adrienne W Paton, James C Paton, Masanori Kitamura.   

Abstract

Subtilase cytotoxin (SubAB) that selectively cleaves BiP/GRP78 triggers the unfolded protein response (UPR) and protects mice from endotoxic lethality and collagen arthritis. We found that pretreatment of cells with SubAB suppressed tumor necrosis alpha (TNF-α)-induced activation of NF-κB and NF-κB-dependent chemokine expression. To elucidate underlying mechanisms, the involvement of C/EBP and Akt, putative regulators of NF-κB, was investigated. Among members of the C/EBP family, SubAB preferentially induced C/EBPβ. Overexpression of C/EBPβ suppressed TNF-α-induced NF-κB activation, and knockdown of C/EBPβ attenuated the suppressive effect of SubAB on NF-κB. We identified that the ATF6 branch of the UPR plays a crucial role in the induction of C/EBPβ. In addition to this effect, SubAB depressed basal and TNF-α-induced phosphorylation of Akt via the UPR. It was mediated by the induction of ATF6 and consequent activation of mTOR that dephosphorylated Akt. Inhibition of Akt attenuated activation of NF-κB by TNF-α, suggesting that the mTOR-Akt pathway is another target for SubAB-initiated, UPR-mediated NF-κB suppression. These results elucidated that SubAB blunts activation of NF-κB through ATF6-dependent mechanisms, i.e., preferential induction of C/EBPβ and mTOR-dependent dephosphorylation of Akt.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300786      PMCID: PMC3126329          DOI: 10.1128/MCB.00939-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Regulation of internal ribosomal entry site-mediated translation by phosphorylation of the translation initiation factor eIF2alpha.

Authors:  James Fernandez; Ibrahim Yaman; Peter Sarnow; Martin D Snider; Maria Hatzoglou
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

Review 2.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

Authors:  Y Yamamoto; R B Gaynor
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations.

Authors:  T Katayama; K Imaizumi; A Honda; T Yoneda; T Kudo; M Takeda; K Mori; R Rozmahel; P Fraser; P S George-Hyslop; M Tohyama
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

Review 4.  CCAAT/enhancer-binding proteins: structure, function and regulation.

Authors:  Dipak P Ramji; Pelagia Foka
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

5.  CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation.

Authors:  S Prösch; A K Heine; H D Volk; D H Krüger
Journal:  J Biol Chem       Date:  2001-08-24       Impact factor: 5.157

6.  ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response.

Authors:  H Yoshida; T Okada; K Haze; H Yanagi; T Yura; M Negishi; K Mori
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.

Authors:  F Tremblay; A Marette
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

8.  Amino acids control mammalian gene transcription: activating transcription factor 2 is essential for the amino acid responsiveness of the CHOP promoter.

Authors:  A Bruhat; C Jousse; V Carraro; A M Reimold; M Ferrara; P Fafournoux
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 9.  From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.

Authors:  D Ehninger; P J de Vries; A J Silva
Journal:  J Intellect Disabil Res       Date:  2009-08-19

10.  Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck.

Authors:  Fa-Yu Liu; Zhen-Jin Zhao; Peng Li; Xue Ding; Zhi-Hong Zong; Chang-Fu Sun
Journal:  Br J Oral Maxillofac Surg       Date:  2009-07-16       Impact factor: 1.651

View more
  52 in total

Review 1.  Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.

Authors:  Sujatha Muralidharan; Pranoti Mandrekar
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

2.  Endoplasmic reticulum stress-induced degradation of DNAJB12 stimulates BOK accumulation and primes cancer cells for apoptosis.

Authors:  Pattarawut Sopha; Hong Yu Ren; Diane E Grove; Douglas M Cyr
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

Review 3.  The unfolded protein response triggered by environmental factors.

Authors:  Masanori Kitamura
Journal:  Semin Immunopathol       Date:  2013-04-04       Impact factor: 9.623

Review 4.  Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?

Authors:  David S Hill; Penny E Lovat; Nikolas K Haass
Journal:  Melanoma Manag       Date:  2014-12-04

Review 5.  The impact of the endoplasmic reticulum protein-folding environment on cancer development.

Authors:  Miao Wang; Randal J Kaufman
Journal:  Nat Rev Cancer       Date:  2014-09       Impact factor: 60.716

6.  Influenza A viral replication is blocked by inhibition of the inositol-requiring enzyme 1 (IRE1) stress pathway.

Authors:  Ihab H Hassan; Michael S Zhang; Linda S Powers; Jian Q Shao; Jonas Baltrusaitis; D Thomas Rutkowski; Kevin Legge; Martha M Monick
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

7.  Cordycepin as a sensitizer to tumour necrosis factor (TNF)-α-induced apoptosis through eukaryotic translation initiation factor 2α (eIF2α)- and mammalian target of rapamycin complex 1 (mTORC1)-mediated inhibition of nuclear factor (NF)-κB.

Authors:  M Kadomatsu; S Nakajima; H Kato; L Gu; Y Chi; J Yao; M Kitamura
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

8.  Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.

Authors:  Stephanie T Stengel; Antonella Fazio; Simone Lipinski; Martin T Jahn; Konrad Aden; Go Ito; Felix Wottawa; Jan W P Kuiper; Olivia I Coleman; Florian Tran; Dora Bordoni; Joana P Bernardes; Marlene Jentzsch; Anne Luzius; Sandra Bierwirth; Berith Messner; Anna Henning; Lina Welz; Nassim Kakavand; Maren Falk-Paulsen; Simon Imm; Finn Hinrichsen; Matthias Zilbauer; Stefan Schreiber; Arthur Kaser; Richard Blumberg; Dirk Haller; Philip Rosenstiel
Journal:  Gastroenterology       Date:  2020-07-13       Impact factor: 22.682

9.  Inositol-requiring enzyme 1 inhibits respiratory syncytial virus replication.

Authors:  Ihab Hassan; Kayla S Gaines; Wesley J Hottel; Ryan M Wishy; Sara E Miller; Linda S Powers; D Thomas Rutkowski; Martha M Monick
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

10.  Subtilase cytotoxin enhances Escherichia coli survival in macrophages by suppression of nitric oxide production through the inhibition of NF-κB activation.

Authors:  Hiroyasu Tsutsuki; Kinnosuke Yahiro; Kotaro Suzuki; Akira Suto; Kohei Ogura; Sayaka Nagasawa; Hideshi Ihara; Takeshi Shimizu; Hiroshi Nakajima; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2012-09-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.